Discovery and development of potent and selective dual NUAK/MARK inhibitors as Hippo pathway modulators for the treatment of cancer

Read full text Summarise with VIRAT
Authors: David V. Smil, Yong Ge LIU, Tao Xin, Taira Kiyota, Ahmed M. Aman, Julie Grouleff, Laurent Hoffer, Dhananjay Joshi, Mohammad Reza Inanlou, Siyuan Song, Daniel Y.L. Mao, Abiodun A. Ogunjimi
+11 more Victor P.T. Pau, Fiona D. Chini, Igor V. Kurinov, Ying Zhang (40767), Anh Thu Nguyen, Jeffrey L. Wrana, Frank Sicheri, Liliana Attisano, David Uehling, Rima Al‐awar, Methvin B. Isaac
Cited by: 0
References: 47

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Hippo pathway signaling and YAP/TAZ PI3K/AKT/mTOR signaling in cancer Protein Kinase Regulation and GTPase Signaling

Publication details

Journal / source
European Journal of Medicinal Chemistry
Volume
311
Pages
118798–118798
Publication date
31 March 2026
Language
EN